NAD on Immune Nutrisoda
This article was originally published in The Tan Sheet
Executive SummaryPepsiAmericas subsidiary Ardea Beverages will discontinue a print advertisement for Immune Nutrisoda following a determination by the National Advertising Division that "the advertisement went beyond simple structure/function claims." The ad, which featured images of a can of the product and an airplane, stated "protection from seat 33b." Other claims in the ad included "Immune Nutrisoda doesn't just refresh you, it revitalizes you....It's full of the right stuff to help support your body's immune defenses." The images and statements in the spot "combine to convey a message that this product will do more than simply provide vitamins and minerals that will help to maintain a healthy immune system," NAD concludes in a Nov. 21 decision. Ardea "respectfully disagrees" with NAD's assessment, but says it will take the suggestions into consideration in planning future advertisements...
You may also be interested in...
Eighteen years of free trade threatens to crash, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.